Why PCOS Causes Weight Gain: Four Mechanisms, Not Willpower
11 min read
A registered dietitian and clinician review is being arranged for this site. Until this article carries a named reviewer, treat it as a well-sourced summary of published guidance — not as a substitute for advice about your own case.
The short answer
PCOS weight gain runs through four measurable mechanisms: insulin resistance runs 27% higher regardless of body weight, androgens shift where fat sits, appetite hormones tilt toward hunger, and resting energy expenditure may run lower in some studies but not others. None of the four is about effort — each is testable, and each responds to a different treatment.
Does PCOS Actually Make You Gain Weight?
PCOS does not cause weight gain in everyone who has it, but it does change the biology that governs weight in most people who have it. Roughly half of people with PCOS carry a body weight in the overweight or obesity range, and the mechanisms below explain a real biological pull toward fat storage that exists independently of what a person eats or how much they move — which is why “eat less, move more” alone so often fails to move the number for this specific population.
That distinction matters because PCOS is diagnosed by ovarian and hormonal criteria, not by body weight. A normal-weight person can have PCOS with the identical hormonal and metabolic drivers described below — clinicians sometimes call this presentation “lean PCOS” — and a person with a larger body can have none of these drivers active. Weight is a downstream marker in this condition, not the diagnosis, and not the target that matters most for managing it. The 2023 international guideline for PCOS explicitly names weight stigma as something clinicians should account for when discussing metabolic care — a reflection of how often weight gets treated as the whole story here when it is one marker among several.
Do Ovarian Cysts Cause the Weight Gain?
No — the follicles seen on an ultrasound do not produce the hormones responsible for weight gain, and they are not cysts in the surgical sense. They are small, immature egg follicles that failed to release an egg, and they sit there as a visible marker of the hormonal pattern, not a cause of it. The name “polycystic ovary syndrome” describes an ultrasound finding that is present in some people with the condition and absent in others; it was never a description of the metabolic mechanism, which is exactly why the name changed.
In May 2026, a global consensus of more than 50 medical organisations — published in The Lancet — renamed the condition polyendocrine metabolic ovarian syndrome, or PMOS. The new name drops “ovary” from the center of the label on purpose, because the four mechanisms below run through insulin, fat tissue, appetite signaling and the ovary together — not the ovary alone. This article uses PCOS because that is still what most people search, but the four mechanisms are the same under either name.
Mechanism One: How Excess Insulin Pushes Fat Into Storage
Insulin sensitivity runs about 27% lower in PCOS than in people without it, independent of body mass index, according to a meta-analysis of 28 gold-standard clamp studies — the most accurate direct measurement of insulin resistance available. That gap exists in thinner bodies as well as larger ones, which is the first sign that this mechanism is not a consequence of eating patterns.
The chain runs like this. Cells in muscle, fat and liver respond less to insulin’s signal, so the pancreas releases more of it to hold blood sugar steady. Insulin is also a storage hormone — at chronically elevated levels, it pushes fat cells to take up more fatty acids and blocks the enzyme that would otherwise release them for fuel. The result is a metabolic environment tilted toward storing energy rather than releasing it, running in the background regardless of what is eaten in a given day. A full walkthrough of this pathway, including how it is tested, is in insulin resistance and PCOS.
Mechanism Two: What Androgens Actually Do to Fat Distribution
Adipose tissue itself functions differently in PCOS — even in people who are not carrying excess body fat — according to a 2023 review of adipose tissue dysfunction in PCOS, which found impaired fat-cell development, disrupted fat-releasing signals, and altered hormone output from fat tissue itself as recurring findings across the research it examined. Higher androgen levels are one contributor to that dysfunction, alongside insulin.
But the two drivers are not equal, and the honest answer is that insulin resistance carries more of the weight-gain mechanism than androgens do. A 2025 study comparing fat distribution, insulin resistance, androgen levels and inflammatory markers in 35 women with PCOS against 37 BMI-matched controls found higher androgens and higher insulin resistance in the PCOS group, but insulin resistance tracked with body composition far more closely than either androgens or inflammatory cytokines did. Androgens shift where fat is stored — more centrally, less on the hips — more than they explain how much fat accumulates overall.
There is a second, less-discussed piece of the same 2023 adipose review worth naming: it describes impaired adipogenesis in PCOS — meaning fat cells struggle to divide and form new, smaller storage units the way they normally would. When fat tissue cannot expand by making more cells, the existing cells enlarge instead. Enlarged fat cells are metabolically worse than an equivalent amount of fat spread across more, smaller cells — they release more inflammatory signaling molecules and become less responsive to insulin themselves, feeding back into mechanism one. This is a structural explanation for why two people can carry an identical amount of body fat and have meaningfully different metabolic profiles, and it has nothing to do with what either person eats.
Mechanism Three: Are Appetite Hormones Actually Different in PCOS?
Higher insulin levels correlate with higher leptin and lower ghrelin in PCOS, according to a 2024 meta-analysis pooling case-control studies — a moderate positive relationship between insulin and leptin (r = 0.56) and a moderate negative relationship between insulin and ghrelin (r = -0.33). Leptin normally signals fullness and ghrelin normally signals hunger, so this pattern sounds backwards for someone gaining weight — more fullness signal, less hunger signal — and that mismatch is itself informative.
The likely explanation is leptin resistance: enough leptin is present, but the brain stops responding to it the way insulin-resistant tissue stops responding to insulin. The net appetite effect in real life often still tilts toward more hunger and less satiety, particularly a few hours after carbohydrate-heavy meals, when insulin spikes and then drops blood sugar hard on the way back down. That crash-and-hunger cycle is a chemical signal, not a lack of self-control, and it is covered in more mechanistic detail in insulin resistance and PCOS. The authors of the 2024 meta-analysis note the relationship is likely multifactorial and that further research is needed to isolate which factor is driving which — an honest caveat worth keeping in mind before treating appetite hormones as a fully solved piece of the picture.
Mechanism Four: Does PCOS Actually Lower Energy Expenditure?
This is the most contested of the four mechanisms, and two recent studies reached different conclusions using different methods. A 2017 study measured total daily energy expenditure directly using doubly labeled water — the gold-standard method — in 28 weight-stable women with PCOS, and found that standard prediction equations estimated their energy needs accurately, within 4% to 6% of the measured value. Hyperinsulinemia correlated with the equations’ estimates but was not an independent predictor of total energy expenditure once other factors were accounted for.
A larger 2024 study measuring resting energy expenditure by indirect calorimetry in 266 women with PCOS against 51 controls found something different: resting energy expenditure corrected for fat-free mass ran lower in every PCOS subgroup tested — 31.8 versus 35.4 kcal per kilogram of fat-free mass per day — independent of phenotype and BMI category. Its authors were careful to flag their own limitation: because the reduction showed up in normal-weight participants too, something beyond fat mass must be driving it, and a cross-sectional design cannot establish whether the lower rate causes weight gain or results from it.
The two studies are not necessarily contradicting each other so much as measuring different things. Resting energy expenditure is what the body burns at rest, before any activity is added; total daily energy expenditure adds movement, digestion and daily activity on top of that. It is possible for resting expenditure to run slightly lower per kilogram of lean mass while total daily expenditure still comes out close to what standard equations predict, if physical activity happens to be somewhat higher in the group being measured. Neither study proves the other wrong — they highlight how much still depends on exactly what is measured, in whom, and how.
| Mechanism | Strength of evidence | What’s settled | What’s still contested |
|---|---|---|---|
| Insulin resistance and fat storage | Strong — clamp-study meta-analysis | 27% lower insulin sensitivity, independent of BMI | How much of downstream fat storage it explains alone |
| Androgens and fat distribution | Moderate — comparative cohort data | Higher androgens correlate with central fat placement | Whether androgens or insulin resistance is the primary driver |
| Appetite hormones | Moderate — meta-analysis of correlational studies | Insulin correlates with higher leptin, lower ghrelin | Whether the hormones drive weight gain or result from it |
| Reduced energy expenditure | Weak-to-moderate — conflicting study designs | Some studies find lower resting expenditure per kg fat-free mass | Doubly labeled water study found no independent effect on total daily expenditure |
Which Mechanism Is Driving Your Weight Gain?
Not every person with PCOS has all four mechanisms active, and which one dominates changes what actually helps. If your presentation is the classic pattern — irregular cycles, higher androgens, acanthosis nigricans — insulin resistance is very likely doing most of the work, and steps that lower circulating insulin are the most direct lever available. If your presentation is closer to “lean PCOS” with a normal BMI but the same hormonal profile, the same insulin-driven mechanism can still apply; body size is not a reliable indicator of which mechanisms are active underneath it.
If your weight gain tracks closely with acne, hair growth or hair thinning rather than with cycle irregularity, androgens may be playing a larger relative role in your case, and the fat redistribution described in mechanism two is worth investigating specifically.
Two other patterns show up often enough in clinical practice to name, even though they sit outside the four mechanisms above. Some people notice weight climbing in the months after stopping combined hormonal contraception, as androgen levels rebound before settling — a timing clue rather than a new diagnosis, and one that typically eases within several months. Others test normal for insulin and normal for androgens and still gain weight that will not respond to consistent effort; for that group, chronic stress and elevated cortisol are a more plausible driver than any of the four mechanisms above, since cortisol independently promotes central fat storage and can worsen insulin sensitivity on its own. And if none of the above fits — normal insulin, normal androgens, no recent medication change, and weight gain that still will not respond — the honest next step is ruling out other causes entirely, which cannot lose weight with PCOS walks through as a systematic checklist.
This Will Not Fully Explain Everything
These four mechanisms describe population-level patterns from research, not a guarantee about any individual case. Some people with a confirmed PCOS diagnosis and confirmed insulin resistance still do not gain weight easily, and some people without any of these four mechanisms active still struggle with it — genetics, medication history, sleep, and conditions unrelated to PCOS entirely all contribute outside of what is described here. None of the four mechanisms above is a target weight to hit or a number to chase; they are testable biological patterns that explain why the standard advice underperforms for this specific population, not a verdict on any one person’s effort.
Common questions
Does PCOS make you gain weight even if you eat well and exercise?
Yes, for many people — insulin resistance, androgen-driven fat redistribution, and altered appetite hormones can promote fat storage independently of diet quality or activity level. The mechanisms are metabolic, not behavioral.Do ovarian cysts cause weight gain in PCOS?
No. The follicles seen on ultrasound are a marker of the underlying hormonal pattern, not a producer of the hormones responsible for weight gain. Insulin, androgens, and appetite hormones drive the weight-gain mechanism.Can you have PCOS weight gain at a normal BMI?
Yes. Insulin resistance and its downstream effects on fat storage and distribution occur in normal-weight PCOS (sometimes called lean PCOS) as well as in higher-weight presentations, at similar rates on clamp testing.Does PCOS definitely slow your metabolism?
The evidence is mixed. A 2024 study found lower resting energy expenditure per kilogram of fat-free mass in PCOS; a 2017 study using the gold-standard doubly labeled water method found standard equations predicted total energy needs accurately. Both are real, well-designed studies with different conclusions.Which PCOS weight-gain mechanism is the strongest?
Insulin resistance has the strongest evidence, running about 27% lower insulin sensitivity independent of BMI in a meta-analysis of 28 clamp studies. Androgen-driven fat redistribution and appetite-hormone changes have real but comparatively weaker evidence behind them.Is PCOS weight gain reversible?
The mechanisms behind it — insulin resistance, fat-cell dysfunction, appetite-hormone shifts — respond to treatment aimed at each one directly, and research trials do show those markers improving. Reversal is measured in metabolic markers moving in a better direction, not in a guaranteed target weight.
- Cannot Lose Weight With PCOS? Nine Things to Check Before Cutting FurtherPCOS weight loss plateaus for testable reasons — thyroid, iron, sleep apnoea, medication, adaptive metabolism. Nine checks before cutting calories further.
- GLP-1 Drugs for PCOS: Semaglutide, Tirzepatide and What Happens When You StopSemaglutide and tirzepatide move weight in PCOS, but most returns after stopping and muscle goes with it. What the trials show, and what to ask a prescriber.
- Insulin Resistance and PCOS: What's Actually Happening, and What HelpsInsulin resistance runs 27% higher in PCOS regardless of weight. Here's the mechanism, how it's tested, and what diet and metformin trials actually moved.
- Treating Insulin Resistance in PCOS: What Moves HOMA-IR, RankedVigorous exercise cut HOMA-IR by 36% in trials, more than diet, inositol or berberine did. Ranked effect sizes, and why metformin sometimes doesn't move it.
Sources
- 1.Cassar S, Misso ML, Hopkins WG, et al. Insulin Resistance in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Euglycaemic-Hyperinsulinaemic Clamp Studies. Hum Reprod. 2016.
- 2.Bril F, Ezeh U, Amiri M, et al. Adipose Tissue Dysfunction in Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023.
- 3.de Melo Cavalcante RB, Leão LMCSM, Tavares ABW, et al. Fat Distribution and Its Correlation With Insulin Resistance, Androgen Markers, and Proinflammatory Cytokines in Polycystic Ovary Syndrome. Horm Metab Res. 2025.
- 4.Reesor M, Goudiaby Y, Grossett N, et al. Effect of Hyperinsulinemia on Leptin and Ghrelin Levels in Polycystic Ovarian Syndrome: A Meta-Analysis. Cureus. 2024.
- 5.Broskey NT, Klempel MC, Gilmore LA, et al. Assessing Energy Requirements in Women With Polycystic Ovary Syndrome: A Comparison Against Doubly Labeled Water. J Clin Endocrinol Metab. 2017.
- 6.Tosi F, Rosmini F, Gremes V, et al. Resting Energy Expenditure in Women With Polycystic Ovary Syndrome. Hum Reprod. 2024.
- 7.Teede HJ, Tay CT, Laven JJE, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023.
- 8.Teede HJ, Khomami MB, Morman R, et al. Polyendocrine Metabolic Ovarian Syndrome, the New Name for Polycystic Ovary Syndrome: A Multistep Global Consensus Process. Lancet. 2026.